Skip to main content
Premium Trial:

Request an Annual Quote

Bayer Healthcare Extends License to Linguamatics/BioWisdom System

NEW YORK (GenomeWeb News) - Linguamatics and BioWisdom said last week that Bayer Healthcare has extended a license to a joint solution built upon Linguamatics' I2E text-mining software and BioWisdom taxonomies.
 
Bayer’s Scientific Information and Documentation team uses I2E to “solve a diverse range of knowledge discovery problems across the business,” Linguamatics and BioWisdom said.
 
Financial details of the deal were not disclosed.
 
“We recognize the value that text mining with high quality taxonomies can bring to solving our business problems", said Wolfgang Thielemann, head of document retrieval at Bayer Healthcare, in a statement.

Filed under

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.